CenterBook Partners LP purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,614 shares of the biotechnology company’s stock, valued at approximately $6,308,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock valued at $5,019,886,000 after buying an additional 275,959 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Axon Enterprise by 3.7% in the 4th quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company’s stock valued at $1,095,542,000 after acquiring an additional 65,097 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of Axon Enterprise by 273.8% during the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock valued at $659,128,000 after acquiring an additional 812,337 shares in the last quarter. Norges Bank bought a new position in Axon Enterprise during the fourth quarter worth $482,081,000. Finally, GQG Partners LLC acquired a new position in Axon Enterprise in the fourth quarter worth $478,349,000. Institutional investors own 79.08% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on AXON shares. Barclays reissued a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Finally, TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $604.67.
Axon Enterprise Stock Performance
Axon Enterprise stock opened at $504.03 on Wednesday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The firm’s 50 day simple moving average is $574.82 and its 200-day simple moving average is $557.07. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $38.62 billion, a P/E ratio of 130.24, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13.
Insider Buying and Selling
In other news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 6.10% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- What Are Dividends? Buy the Best Dividend Stocks
- Top 3 S&P 500 Winners in a Losing Market
- Why is the Ex-Dividend Date Significant to Investors?
- General Motors: When Good News Isn’t Good Enough
- How to trade penny stocks: A step-by-step guide
- 3 Health Insurance Stocks Holding Green in Market Turmoil
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.